Holen Sie sich die Stockscreener-App
18.73
0.05%
-0.00
Schlusskurs vom Vortag:
$18.73
Offen:
$18.74
24-Stunden-Volumen:
410.64K
Relative Volume:
1.18
Marktkapitalisierung:
$521.30M
Einnahmen:
$242.12M
Nettoeinkommen (Verlust:
$-351.72M
KGV:
-1.4093
EPS:
-13.29
Netto-Cashflow:
$24.82M
1W Leistung:
+121.81%
1M Leistung:
+108.94%
6M Leistung:
+30.37%
1J Leistung:
-13.77%
1-Tages-Spanne:
$18.72
$18.76
1-Wochen-Bereich:
$18.70
$18.98
52-Wochen-Spanne:
$8.15
$22.04
Zimvie Inc Stock (ZIMV) Company Profile
Firmenname
Zimvie Inc
Sektor
Branche
Telefon
800-342-5454
Adresse
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Vergleichen Sie ZIMV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
18.72 | 529.61M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
126.54 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 159.43B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
402.67 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.89 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.52 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-04-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2024-05-16 | Hochstufung | Needham | Hold → Buy |
| 2023-11-16 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Underweight |
| 2022-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-03-18 | Eingeleitet | Guggenheim | Neutral |
Alle ansehen
Zimvie Inc Aktie (ZIMV) Neueste Nachrichten
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - Yahoo Finance
What drives ZimVie Inc. stock priceGame-changing returns - Autocar Professional
ZimVie inks exclusive dental implant distro deal with Osstem in China - MassDevice
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China - The Manila Times
ZimVie partners with Osstem Implant to expand in Chinese dental market By Investing.com - Investing.com South Africa
ZimVie partners with Osstem Implant to expand in Chinese dental market - Investing.com UK
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System - sg.finance.yahoo.com
ZimVie Targets Massive 10M Unit Chinese Dental Market Through Exclusive Osstem Partnership - Stock Titan
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
ZimVie Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
Is ZimVie Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc.ZIMV - The Globe and Mail
Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers - insights.citeline.com
ARCHIMED To Buy ZimVie In $730 Million Deal - Pulse 2.0
ZimVie upgraded to Equal Weight from Underweight at Barclays - TipRanks
ZimVie to sell to investment firm for about $730M - MedTech Dive
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger - Investing.com Australia
What analysts say about ZimVie Inc. stockHigh-yield portfolio picks - jammulinksnews.com
Dental Implants and Prosthetics Market is projected to reach US$ - openPR.com
ARCHIMED to acquire life sciences company ZimVie for $730m - Yahoo Finance
ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan - MSN
Latham & Watkins Advises ARCHIMED in US$730 Million Acquisition of ZimVie Inc. - Latham & Watkins LLP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.
ZimVie Sells For $730 Million In Archimed Buyout - Finimize
ArchiMed To Acquire ZimVie in $730M Deal - USA Herald
Latham And Cravath Steer $730M ZimVie Take-Private Deal - Law360
ZimVie Acquired by Archimed Affiliate for $730 Million, Going Private - Medical Device and Diagnostic industry
Small Medtech Catapults 122% On Its Second Takeover Deal - Investor's Business Daily
ZimVie to be acquired by Archimed in $730M deal - MassDevice
ZimVie stock soars after $730 million acquisition deal with ARCHIMED By Investing.com - Investing.com Canada
ZimVie stock soars after $730 million acquisition deal with ARCHIMED - Investing.com India
The ZimVie Takeover: A Strategic Bet on Dental Innovation and MedTech Consolidation - AInvest
Hold Rating Maintained on ZimVie Inc Amid Acquisition by ARCHIMED - TipRanks
ZimVie's $730M Take-Private by Archimed: A Strategic Exit and Value Realization Opportunity - AInvest
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
Shareholder Alert: The Ademi Firm Investigates Whether ZimVie Inc. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
Dental devicemaker ZimVie to be bought by ArchiMed in $730M deal - Fierce Biotech
ZimVie shares surge after go-private deal with Archimed - TradingView
ZimVie to be acquired by ARCHIMED in $730 million deal - Investing.com
ZIMV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ZimVie Inc. Is Fair to Shareholders - Business Wire
ZimVie Stock (ZIMV) Rockets 120% on ARCHIMED Deal - TipRanks
ZimVie Stock Soars 121.92% on ARCHIMED Acquisition Deal - AInvest
ZimVie to be acquired by ARCHIMED for $19.00 per share in cash - TipRanks
ZimVie Inc to be Acquired by ARCHIMED - TipRanks
ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash - The Manila Times
Dental Tech Leader ZimVie Gets Massive 99% Premium in $730M ARCHIMED Buyout Deal - Stock Titan
Finanzdaten der Zimvie Inc-Aktie (ZIMV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zimvie Inc-Aktie (ZIMV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
| Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
| Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
| Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
| Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
| Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
| Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
| Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
| Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
| Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
0.38%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):